Sylvain Ladoire

18.4k citations
186 papers · 7.5k indexed · 2 hit papers · h-index 40
Topics
Cancer Immunotherapy and Biomarkers (43 papers)Renal cell carcinoma treatment (24 papers)Breast Cancer Treatment Studies (23 papers)
Partner nations
FranceUnited StatesItaly

In The Last Decade

Sylvain Ladoire

179 papers receiving 7.4k citations

Hit Papers

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid...200620262012201920102006250500750

Peers

Sylvain Ladoire
Comparison fields: 5 of 125
  • Oncology 4.3k
  • Immunology 3.3k
  • Molecular Biology 1.4k
  • Pulmonary and Respiratory Medicine 1.2k
  • Cancer Research 884
Replace Shinji Nakao with:
Shinji Nakao Japan
Bo Zhu China
Marco Alifano France
Isaac E. Stillman United States
Giuseppe Grandaliano Italy
Gilbert Deray France
Markus Guba Germany
Pavan Reddy United States
Michael von Bergwelt‐Baildon Germany
Vinod P. Balachandran United States
Sylvain Ladoire relative to Shinji Nakao Japan Shinji Nakao's profile →
Citations per field
00.5×2.8×
Shinji Nakao · 1×
Citations per year

Countries citing papers authored by Sylvain Ladoire

Since Specialization
Citations

This map shows the geographic impact of Sylvain Ladoire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Ladoire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Ladoire more than expected).

Fields of papers citing papers by Sylvain Ladoire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Ladoire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Ladoire. The network helps show where Sylvain Ladoire may publish in the future.

Co-authorship network of co-authors of Sylvain Ladoire

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Ladoire. A scholar is included among the top collaborators of Sylvain Ladoire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Ladoire. Sylvain Ladoire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 3
4 1
5 17
6 28
7 8
8 5
9 6
10 23
11 17
12 4
13 11
14 48
15 213
16 47
17 37
18
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunitybreakdown →
969
19 18
20 142

About Sylvain Ladoire

Sylvain Ladoire is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 186 papers that have together received 7.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), Renal cell carcinoma treatment (24 papers) and Breast Cancer Treatment Studies (23 papers). The work is most often cited by research in Oncology (4.3k citations), Immunology (3.3k citations) and Cancer Research (884 citations). Sylvain Ladoire has collaborated with scholars based in France, United States and Italy. Frequent co-authors include François Ghiringhelli, François Martin, Lionel Apétoh, Cédric Rébé, Grégoire Mignot, Bruno Chauffert, Julie Vincent, Fanny Chalmin, Laurence Zitvogel and Mélanie Bruchard. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026